NTRA · Natera, Inc. · Webcasts, Transcripts & Audio
$319.09
-3.85 (-1.19%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$46.27B
Shares
145.00M
Volume · Nov 13
1.69M
Avg daily vol (3M)
1.72M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Natera, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Natera, Inc. (NTRA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-10
Natera, Inc. (NTRA) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-09
Natera, Inc. (NTRA) November 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-05
Natera, Inc. (NTRA) Q3 2026 Earnings Call Transcript
Confident tone
Signatera volume and revenue growth
Raised guidance and long-term revenue target
Expanded reimbursement and geographic access
Revenue
$793.98M
▲ 34.1% YoY Diluted EPS
$-0.42
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Natera, Inc. (NTRA) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-14
Natera, Inc. (NTRA) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-08-12
Natera, Inc. (NTRA) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Natera, Inc. (NTRA) Q2 2026 Earnings Call Transcript
Confident tone
Signatera Oncology Momentum
Gross Margin and COGS
International Expansion (Japan)
Revenue
$752.75M
▲ 37.7% YoY Diluted EPS
$-0.47
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Natera, Inc. (NTRA) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript
Confident tone
Oncology / Signatera MRD Growth
Reimbursement and Prior Authorization
Fetal Focus Product Launch (Women's Health)
Revenue
$696.64M
▲ 38.8% YoY Diluted EPS
$-0.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Natera, Inc. (NTRA) Q4 2025 Earnings Call Transcript
Confident tone
Revenue Growth and 2026 Guidance
MRD Volume and Adoption
Gross Margin Expansion
Revenue
$665.50M*
▲ 39.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Natera, Inc. (NTRA) Q3 2025 Earnings Call Transcript
Confident tone
Signatera MRD growth and momentum
Gross margin expansion and ASP improvement
Revenue and 2025 financial guidance raise
Revenue
$592.18M
▲ 34.7% YoY Diluted EPS
$-0.64
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Natera, Inc. (NTRA) Q2 2025 Earnings Call Transcript
Confident tone
Signatera oncology volume growth
Gross margin expansion
Medicare reimbursement expansion for noncovered indications
Revenue
$546.60M
▲ 32.2% YoY Diluted EPS
$-0.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Natera, Inc. (NTRA) Q1 2025 Earnings Call Transcript
Confident tone
Signatera oncology growth
Gross margin expansion
Clinical data and study readouts
Revenue
$501.83M
▲ 36.5% YoY Diluted EPS
$-0.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Natera, Inc. (NTRA) Q4 2024 Earnings Call Transcript
Confident tone
Signatera oncology growth
Gross margin and COGS progress
2025 guidance and execution risk
Revenue
$476.06M*
▲ 53% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Natera, Inc. (NTRA) Q3 2024 Earnings Call Transcript
Confident tone
Signatera oncology volumes
Reimbursement and ASP improvement
Women's health and Invitae integration
Revenue
$439.76M
▲ 63.9% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Natera, Inc. (NTRA) Q2 2024 Earnings Call Transcript
Confident tone
Signatera Oncology
Revenue Growth and Guidance Raise
ALTAIR Trial Delay
Revenue
$413.35M
▲ 58.1% YoY Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Natera, Inc. (NTRA) Q1 2024 Earnings Call Transcript
Confident tone
Signatera / Oncology Performance
Gross Margin Expansion
Women's Health Momentum
Revenue
$367.74M
▲ 52.1% YoY Diluted EPS
$-0.56
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Natera, Inc. (NTRA) Q4 2023 Earnings Call Transcript
Confident tone
Revenue and Volume Growth
Oncology / Signatera
Women's Health and Invitae Acquisition
Revenue
$311.11M*
▲ 43.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript
Revenue
$268.31M
▲ 27.4% YoY Diluted EPS
$-0.95
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Natera, Inc. (NTRA) Q2 2023 Earnings Call Transcript
Revenue
$261.40M
▲ 31.9% YoY Diluted EPS
$-0.97
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Natera, Inc. (NTRA) Q1 2023 Earnings Call Transcript
Revenue
$241.76M
▲ 24.5% YoY Diluted EPS
$-1.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Natera, Inc. (NTRA) Q4 2022 Earnings Call Transcript
Revenue
$217.25M*
▲ 25.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Natera, Inc. (NTRA) Q3 2022 Earnings Call Transcript
Revenue
$210.64M
▲ 33.2% YoY Diluted EPS
$-1.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Natera, Inc. (NTRA) Q2 2022 Earnings Call Transcript
Revenue
$198.20M
▲ 39.6% YoY Diluted EPS
$-1.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Natera, Inc. (NTRA) Q1 2022 Earnings Call Transcript
Revenue
$194.13M
▲ 27.5% YoY Diluted EPS
$-1.45
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Natera, Inc. (NTRA) Q4 2021 Earnings Call Transcript
Revenue
$173.03M*
▲ 54% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Natera, Inc. (NTRA) Q3 2021 Earnings Call Transcript
Revenue
$158.12M
▲ 61.1% YoY Diluted EPS
$-1.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Natera, Inc. (NTRA) Q2 2021 Earnings Call Transcript
Revenue
$142.03M
▲ 64.2% YoY Diluted EPS
$-1.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Natera, Inc. (NTRA) Q1 2021 Earnings Call Transcript
Revenue
$152.32M
▲ 62% YoY Diluted EPS
$-0.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Natera, Inc. (NTRA) Q4 2020 Earnings Call Transcript
Revenue
$112.38M*
▲ 35% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Natera, Inc. (NTRA) Q3 2020 Earnings Call Transcript
Revenue
$98.14M
▲ 26% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Natera, Inc. (NTRA) Q2 2020 Earnings Call Transcript
Revenue
$86.47M
▲ 16.3% YoY Gross margin
50.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Natera, Inc. (NTRA) Q1 2020 Earnings Call Transcript
Revenue
$94.01M
▲ 40.7% YoY Gross margin
55.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-26
Natera, Inc. (NTRA) Q4 2019 Earnings Call
Revenue
$83.24M
▲ 24.3% YoY Diluted EPS
$-0.46
Gross margin
46.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–34 of 34 webcasts
Key facts
CIK
1604821
CUSIP
632307104
13F (30d)
729 filings
674 filers
Visit website
Investor relations